Malmö, Sweden

Krister Larsson

This inventor holds 4 USPTO granted patents. Top assignees: Ferring Ab, Ferring B.v.. Active years: 1996-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Krister Larsson: Innovator in Pharmaceutical Patents

Introduction

Krister Larsson is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for conditions such as nocturia, incontinence, and diabetes insipidus. With a total of 4 patents to his name, Larsson's work has had a meaningful impact on patient care.

Latest Patents

Larsson's latest patents include innovative processes for the manufacture of high purity desmopressin. One patent focuses on a method for treating nocturia, incontinence, and enuresis using high purity desmopressin produced in single batches of substantial size. Another patent addresses the treatment of diabetes insipidus with the same high purity desmopressin, emphasizing the efficiency of large single batch production.

Career Highlights

Throughout his career, Krister Larsson has worked with prominent companies in the pharmaceutical industry, including Ferring AB and Ferring B.V. His expertise in the field has allowed him to develop groundbreaking solutions that enhance the quality of life for patients suffering from various medical conditions.

Collaborations

Larsson has collaborated with esteemed colleagues such as Jan Roschester and Birgitta Mornstam. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

In summary, Krister Larsson is a distinguished inventor whose work in pharmaceutical patents has led to significant advancements in treatment options for patients. His innovative approaches continue to shape the future of medical care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…